Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.46 |
| ▸ | KCNQ3 | O43525 | 4/20 | 0.46 |
| ▸ | KCNQ2 | O43526 | 4/20 | 0.46 |
| ▸ | KCNQ4 | P56696 | 3/20 | 0.46 |
| ▸ | KCNQ5 | Q9NR82 | 3/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | DHODH | Q02127 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2072355 | 1.00 | UTS2R (0.46) | UTS2RKCNQ3KCNQ2KCNQ4KCNQ5 | |
| SCHEMBL2071657 | 0.88 | KCNQ2 (0.46) | UTS2RKCNQ3KCNQ2KCNQ4KCNQ5 | |
| SCHEMBL30795429 | 0.86 | KCNQ3 (0.47) | KCNQ3KCNQ2KCNQ4KCNQ5FFAR1 | |
| SCHEMBL2069986 | 0.86 | KCNQ3 (0.47) | KCNQ3KCNQ2KCNQ4KCNQ5FFAR1 | |
| SCHEMBL2070740 | 0.86 | SMN1; SMN2 (0.53) | KCNQ3KCNQ2KCNQ4KCNQ5FFAR1 | |
| SCHEMBL30795181 | 0.84 | KCNQ2 (0.62) | KCNQ3KCNQ2KCNQ4KCNQ5FFAR1 | |
| SCHEMBL3101974 | 0.84 | KCNQ2 (0.62) | KCNQ3KCNQ2KCNQ4KCNQ5FFAR1 | |
| SCHEMBL2070853 | 0.84 | KCNQ3 (0.46) | UTS2RKCNQ3KCNQ2KCNQ4KCNQ5 | |
| SCHEMBL30796658 | 0.82 | KCNQ3 (0.44) | KCNQ3KCNQ2KCNQ4KCNQ5FFAR1 | |
| SCHEMBL2071189 | 0.82 | KCNQ3 (0.44) | KCNQ3KCNQ2KCNQ4KCNQ5FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| EP-4580679-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | Biohaven Therapeutics Ltd. (VG) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024054807-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND TDP-43 MODULATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024050389-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-07 | — | — | WO | disclosed |